Amy Cross

1.1k total citations
22 papers, 491 citations indexed

About

Amy Cross is a scholar working on Immunology, Transplantation and Surgery. According to data from OpenAlex, Amy Cross has authored 22 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 7 papers in Transplantation and 5 papers in Surgery. Recurrent topics in Amy Cross's work include Renal Transplantation Outcomes and Treatments (7 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (3 papers). Amy Cross is often cited by papers focused on Renal Transplantation Outcomes and Treatments (7 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (3 papers). Amy Cross collaborates with scholars based in United Kingdom, France and United States. Amy Cross's co-authors include Nuala Mooney, Denis Glotz, Julien Lion, Fadi Issa, Joanna Hester, Karine Poussin, Dominique Charron, Jean‐Luc Taupin, Cécile Taflin and Alain Haziot and has published in prestigious journals such as Nature Genetics, SHILAP Revista de lepidopterología and Kidney International.

In The Last Decade

Amy Cross

22 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Cross United Kingdom 14 184 137 104 97 82 22 491
Ivana R. Ferrer United States 12 355 1.9× 84 0.6× 109 1.0× 56 0.6× 23 0.3× 14 524
T. Andargie United States 9 95 0.5× 49 0.4× 66 0.6× 77 0.8× 39 0.5× 28 274
Manuela Testi Italy 13 157 0.9× 56 0.4× 67 0.6× 20 0.2× 55 0.7× 23 479
Anne Duperrier France 8 213 1.2× 48 0.4× 101 1.0× 53 0.5× 25 0.3× 12 496
Akihiko Tamura Japan 12 98 0.5× 70 0.5× 147 1.4× 142 1.5× 18 0.2× 44 454
Peter R. Millard United Kingdom 13 79 0.4× 67 0.5× 77 0.7× 115 1.2× 148 1.8× 22 572
Chul‐Woo Pyo United States 12 262 1.4× 25 0.2× 46 0.4× 93 1.0× 34 0.4× 34 467
Mikalai Nienen Germany 14 217 1.2× 27 0.2× 114 1.1× 24 0.2× 83 1.0× 18 449
Borel Jf Japan 8 108 0.6× 83 0.6× 140 1.3× 72 0.7× 22 0.3× 18 430
Giada Amodio Italy 16 624 3.4× 25 0.2× 143 1.4× 50 0.5× 24 0.3× 27 805

Countries citing papers authored by Amy Cross

Since Specialization
Citations

This map shows the geographic impact of Amy Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Cross more than expected).

Fields of papers citing papers by Amy Cross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Cross. The network helps show where Amy Cross may publish in the future.

Co-authorship network of co-authors of Amy Cross

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Cross. A scholar is included among the top collaborators of Amy Cross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Cross. Amy Cross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cross, Amy, et al.. (2025). Role of Fibroblast‐Immune Crosstalk in Kidney, Lung, and Skin Tertiary Lymphoid Structures. Immunological Reviews. 334(1). e70059–e70059. 1 indexed citations
2.
Cross, Amy, Matthew O. Brook, Conor Hennessy, et al.. (2024). Regulatory T cell therapy is associated with distinct immune regulatory lymphocytic infiltrates in kidney transplants. Med. 6(5). 100561–100561. 2 indexed citations
3.
Cross, Amy & Fadi Issa. (2024). Unraveling Renal Transplant Rejection: How Can We Measure Intragraft Cell–Cell Interactions?. Transplantation. 108(12). 2304–2305. 1 indexed citations
4.
Cross, Amy, James Michael Harris, Colin Nixon, et al.. (2024). Characterisation of HBV and co-infection with HDV and HIV through spatial transcriptomics. SHILAP Revista de lepidopterología. 2(3). e100067–e100067. 4 indexed citations
5.
Frost, Joe N., Sarah K. Wideman, Megan R. Teh, et al.. (2022). Plasma iron controls neutrophil production and function. Science Advances. 8(40). eabq5384–eabq5384. 45 indexed citations
6.
Wing, Peter A. C., Amy Cross, Stefania Crotta, et al.. (2022). Hypoxia inducible factors regulate infectious SARS-CoV-2, epithelial damage and respiratory symptoms in a hamster COVID-19 model. PLoS Pathogens. 18(9). e1010807–e1010807. 15 indexed citations
7.
Cross, Amy, Carlos E. de Andrea, María Villalba, et al.. (2022). Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune circuits related to tissue injury. JCI Insight. 8(2). 19 indexed citations
8.
Hennessy, Conor, et al.. (2021). Recent advances in our understanding of the allograft response. PubMed. 10. 21–21. 13 indexed citations
9.
Cross, Amy, et al.. (2021). Case Report: PANDAS and Persistent Lyme Disease With Neuropsychiatric Symptoms: Treatment, Resolution, and Recovery. Frontiers in Psychiatry. 12. 505941–505941. 4 indexed citations
10.
Saleem, Adeel, Sim L. Tung, Caroline Dudreuilh, et al.. (2021). Chimeric antigen receptor‐modified human regulatory T cells that constitutively express IL‐10 maintain their phenotype and are potently suppressive. European Journal of Immunology. 51(10). 2522–2530. 28 indexed citations
11.
Downes, Damien J., Amy Cross, Hua Peng, et al.. (2021). Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus. Nature Genetics. 53(11). 1606–1615. 92 indexed citations
12.
Cross, Amy, Julien Lion, Karine Poussin, Denis Glotz, & Nuala Mooney. (2021). Inflammation Determines the Capacity of Allogenic Endothelial Cells to Regulate Human Treg Expansion. Frontiers in Immunology. 12. 666531–666531. 22 indexed citations
13.
Salter, Amber, June Halper, Bruce F. Bebo, et al.. (2020). Covims registry: clinical characterization of SARS-COV-2 infected multiple sclerosis patients in north america. Multiple Sclerosis Journal. 26. 97–97. 3 indexed citations
14.
Ménoret, Séverine, et al.. (2020). Humanization of Immunodeficient Animals for the Modeling of Transplantation, Graft Versus Host Disease, and Regenerative Medicine. Transplantation. 104(11). 2290–2306. 29 indexed citations
15.
Cross, Amy, Julien Lion, Karine Poussin, et al.. (2019). HLA-DQ alloantibodies directly activate the endothelium and compromise differentiation of FoxP3high regulatory T lymphocytes. Kidney International. 96(3). 689–698. 33 indexed citations
16.
17.
Cross, Amy, Denis Glotz, & Nuala Mooney. (2018). The Role of the Endothelium during Antibody-Mediated Rejection: From Victim to Accomplice. Frontiers in Immunology. 9. 106–106. 37 indexed citations
18.
Lion, Julien, Maren Burbach, Amy Cross, et al.. (2017). Endothelial Cell Amplification of Regulatory T Cells Is Differentially Modified by Immunosuppressors and Intravenous Immunoglobulin. Frontiers in Immunology. 8. 1761–1761. 14 indexed citations
19.
Cross, Amy, Julien Lion, Pascale Loiseau, et al.. (2016). Donor Specific Antibodies are not only directed against HLA-DR: Minding your Ps and Qs. Human Immunology. 77(11). 1092–1100. 22 indexed citations
20.
Lion, Julien, Cécile Taflin, Amy Cross, et al.. (2015). HLA Class II Antibody Activation of Endothelial Cells Promotes Th17 and Disrupts Regulatory T Lymphocyte Expansion. American Journal of Transplantation. 16(5). 1408–1420. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivana R. Ferrer Breakdown of academic impact, for papers by T. Andargie Breakdown of academic impact, for papers by Manuela Testi Breakdown of academic impact, for papers by Anne Duperrier Breakdown of academic impact, for papers by Akihiko Tamura Breakdown of academic impact, for papers by Peter R. Millard Breakdown of academic impact, for papers by Chul‐Woo Pyo Breakdown of academic impact, for papers by Mikalai Nienen Breakdown of academic impact, for papers by Borel Jf Breakdown of academic impact, for papers by Giada Amodio
Rankless by CCL
2026